ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 625505 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 625505; 2) Community: the network communities that were significantly associated with the response to NSC 625505; 3) Molecule: the relationships between components within communities and NSC 625505; 4) MDR: the compounds that were significantly associated with the NSC 625505.

NSC Compound Enrichment Correlation
NSC 723732 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one 0.0414190425892865 0.50852444
NSC 728038 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline 0.0414190425892865 0.39855673
NSC 737231 Null 0.0414190425892865 0.22798713
NSC 740 Methotrexate 0.0414190425892865 0.20584871
NSC 743530 Null 0.0414190425892865 0.46414904
NSC 744063 Null 0.0414190425892865 0.44083404
NSC 747461 Null 0.0414190425892865 0.22086902
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.0414190425892865 0.16401049
NSC 763703 (Z)-6-chloro-3-((2-(4-methoxyphenyl)-3H-benzo[d]imidazol-5-yl)methylene)indolin-2-one 0.0414190425892865 0.37804006
NSC 84074 Phosphonium, (3-bromopropyl)triphenyl- bromide 0.0414190425892865 0.35662787
Total:118  Current:106    [First] [Prev] [Next] [Last]